Andrew Creagh

Andrew is a Junior Research Fellow with the Wearables Group at the BDI. He is also based at the Computational Health Informatics (CHI) laboratory, at the Department of Engineering Science, University of Oxford, and concurrently a Postdoctoral Fellow at GSK, London. 

Andrew’s research aims to explore how we can capture digital biomarkers of disease using consumer digital health technologies (DHT) — collected from smartphone and smartwatch app. sensors and patient reported outcomes (PROs) when patients are at home — to develop personalised monitoring, enhance patient treatment strategies, and ultimately the development of validated digital biomarkers for clinical trial (CT) end-points and prescribed digital therapeutics (DTx). Andrew’s technical areas of expertise include AI/ML for disease prediction, explainable AI (XAI), and time-series analysis. 

Andrew obtained his DPhil. (PhD) in Clinical Machine Learning at the University of Oxford, developing digital biomarkers in collaboration with industrial partners, F. Hoffmann-La Roche. He holds a bachelor’s degree (BAI, BA) in Biomedical Engineering and master’s degree (MAI) in Neural Engineering from Trinity College, the University of Dublin.